Literature DB >> 17124104

Platelets: testing, dosing and the storage lesion--recent advances.

Richard M Kaufman1.   

Abstract

The demand for platelet transfusions continues to grow. Several complementary approaches that may help meet this demand in the future are reviewed. First, platelet bacterial testing is beginning to allow the extension of platelet storage beyond 5 days. Studies are also underway aimed at better preserving viability and function during ex vivo platelet storage: additive solutions and other approaches are being developed to try to negate the "platelet storage lesion." Finally, new approaches to dosing platelets may help extend the limited supply.

Mesh:

Year:  2006        PMID: 17124104     DOI: 10.1182/asheducation-2006.1.492

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  6 in total

1.  Toward a definition of "fresh" whole blood: an in vitro characterization of coagulation properties in refrigerated whole blood for transfusion.

Authors:  David Jobes; Yanika Wolfe; Daniel O'Neill; Jennifer Calder; Lisa Jones; Deborah Sesok-Pizzini; X Long Zheng
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

2.  Towards targeting platelet storage lesion-related signaling pathways.

Authors:  Peter Schubert; Dana V Devine
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

3.  Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions.

Authors:  Seema Kacker; Evan M Bloch; Paul M Ness; Eric A Gehrie; Christi E Marshall; Parvez M Lokhandwala; Aaron A R Tobian
Journal:  Transfusion       Date:  2019-01-08       Impact factor: 3.157

4.  Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice.

Authors:  A J Gerard Jansen; Emma C Josefsson; Viktoria Rumjantseva; Qiyong Peter Liu; Hervé Falet; Wolfgang Bergmeier; Stephen M Cifuni; Robert Sackstein; Ulrich H von Andrian; Denisa D Wagner; John H Hartwig; Karin M Hoffmeister
Journal:  Blood       Date:  2011-11-18       Impact factor: 22.113

5.  Carbamylation of Integrin α IIb β 3: The Mechanistic Link to Platelet Dysfunction in ESKD.

Authors:  Veronika Binder; Barbara Chruścicka-Smaga; Brith Bergum; Stéphane Jaisson; Philippe Gillery; Joar Sivertsen; Tor Hervig; Marta Kaminska; Ronak Tilvawala; Venkatesh V Nemmara; Paul R Thompson; Jan Potempa; Hans-Peter Marti; Piotr Mydel
Journal:  J Am Soc Nephrol       Date:  2022-08-29       Impact factor: 14.978

Review 6.  Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?

Authors:  Giovanni Di Minno; David Navarro; Carlo Federico Perno; Mariana Canaro; Lutz Gürtler; James W Ironside; Hermann Eichler; Andreas Tiede
Journal:  Ann Hematol       Date:  2017-06-18       Impact factor: 3.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.